Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 08:54:50 UTC
Update Date2021-09-26 23:03:36 UTC
HMDB IDHMDB0251549
Secondary Accession NumbersNone
Metabolite Identification
Common NameVadimezan
DescriptionVadimezan, also known as 5,6-mexaa or AS 1404, belongs to the class of organic compounds known as xanthones. These are polycyclic aromatic compounds containing a xanthene moiety conjugated to a ketone group at carbon 9. Xanthene is a tricyclic compound made up of two benzene rings linearly fused to each other through a pyran ring. ASA404 (DMXAA) is a small-molecule vascular disrupting agent which targets the blood vessels that nourish tumours. Vadimezan is an extremely weak basic (essentially neutral) compound (based on its pKa). Vasoactive mediators such as tumor necrosis factor (TNF) may also be implicated. Increased permeability of tumor cell vasculature may allow increased permeation of anticancer treatments such as cytotoxic drugs, antibodies, drug conjugates and gene therapy. The proposed mechanism of action for ASA404 is directly increasing permeability of the tumor's endothelial cells. This compound has been identified in human blood as reported by (PMID: 31557052 ). Vadimezan is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Vadimezan is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
(5,6-Dimethyl-9-oxoxanthen-4-yl)acetic acidChEBI
5,6-Dimethyl-9-oxo-9H-xanthene-4-acetic acidChEBI
5,6-Dimethylxanthenone-4-acetic acidChEBI
5,6-Dimethylxanthenoneacetic acidChEBI
5,6-MeXAAChEBI
AS 1404ChEBI
AS-1404ChEBI
Dimethyloxoxanthene acetic acidChEBI
NSC 640488ChEBI
VadimezanumChEBI
(5,6-Dimethyl-9-oxoxanthen-4-yl)acetateGenerator
5,6-Dimethyl-9-oxo-9H-xanthene-4-acetateGenerator
5,6-Dimethylxanthenone-4-acetateGenerator
5,6-DimethylxanthenoneacetateGenerator
Dimethyloxoxanthene acetateGenerator
ASA-404MeSH
5,6-Dimethylxanthenoneacetic acid, sodium saltMeSH
ASA 404MeSH
5,6-Dimethyl xanthenone acetic acidMeSH
2-(5,6-Dimethyl-9-oxo-9H-xanthen-4-yl)acetateGenerator
VadimezanMeSH
Chemical FormulaC17H14O4
Average Molecular Weight282.2907
Monoisotopic Molecular Weight282.089208936
IUPAC Name2-(5,6-dimethyl-9-oxo-9H-xanthen-4-yl)acetic acid
Traditional Namevadimezan
CAS Registry NumberNot Available
SMILES
CC1=C(C)C2=C(C=C1)C(=O)C1=CC=CC(CC(O)=O)=C1O2
InChI Identifier
InChI=1S/C17H14O4/c1-9-6-7-13-15(20)12-5-3-4-11(8-14(18)19)17(12)21-16(13)10(9)2/h3-7H,8H2,1-2H3,(H,18,19)
InChI KeyXGOYIMQSIKSOBS-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as xanthones. These are polycyclic aromatic compounds containing a xanthene moiety conjugated to a ketone group at carbon 9. Xanthene is a tricyclic compound made up of two benzene rings linearly fused to each other through a pyran ring.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassBenzopyrans
Sub Class1-benzopyrans
Direct ParentXanthones
Alternative Parents
Substituents
  • Xanthone
  • Chromone
  • Pyranone
  • Pyran
  • Benzenoid
  • Heteroaromatic compound
  • Monocarboxylic acid or derivatives
  • Carboxylic acid
  • Carboxylic acid derivative
  • Oxacycle
  • Carbonyl group
  • Hydrocarbon derivative
  • Organic oxide
  • Organooxygen compound
  • Organic oxygen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External Descriptors
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP3.06ALOGPS
logP3.62ChemAxon
logS-4.1ALOGPS
pKa (Strongest Acidic)3.6ChemAxon
pKa (Strongest Basic)-7.7ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area63.6 ŲChemAxon
Rotatable Bond Count2ChemAxon
Refractivity78.21 m³·mol⁻¹ChemAxon
Polarizability29.37 ųChemAxon
Number of Rings3ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+166.74430932474
DeepCCS[M-H]-164.38630932474
DeepCCS[M-2H]-197.27230932474
DeepCCS[M+Na]+172.83830932474
AllCCS[M+H]+163.732859911
AllCCS[M+H-H2O]+159.932859911
AllCCS[M+NH4]+167.232859911
AllCCS[M+Na]+168.232859911
AllCCS[M-H]-168.032859911
AllCCS[M+Na-2H]-167.332859911
AllCCS[M+HCOO]-166.732859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
VadimezanCC1=C(C)C2=C(C=C1)C(=O)C1=CC=CC(CC(O)=O)=C1O23633.4Standard polar33892256
VadimezanCC1=C(C)C2=C(C=C1)C(=O)C1=CC=CC(CC(O)=O)=C1O22506.6Standard non polar33892256
VadimezanCC1=C(C)C2=C(C=C1)C(=O)C1=CC=CC(CC(O)=O)=C1O22748.0Semi standard non polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Vadimezan GC-MS (Non-derivatized) - 70eV, Positivesplash10-000i-1590000000-d4efa2ba1592bc4770252017-08-28Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Vadimezan GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Vadimezan GC-MS (TMS_1_1) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Vadimezan GC-MS (TBDMS_1_1) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Vadimezan 10V, Positive-QTOFsplash10-00lr-0090000000-71bb93a6d50c24e356d52017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Vadimezan 20V, Positive-QTOFsplash10-000i-0090000000-a3673e1da5352e6bdb542017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Vadimezan 40V, Positive-QTOFsplash10-06ri-9260000000-f980944812e96d4fe2392017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Vadimezan 10V, Negative-QTOFsplash10-001r-0090000000-1455ab7323abbdbd81772017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Vadimezan 20V, Negative-QTOFsplash10-0019-1090000000-0189efd89d0cbaf2f9ee2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Vadimezan 40V, Negative-QTOFsplash10-0kmr-5790000000-bc847bc1b3e8c194abf62017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Vadimezan 10V, Positive-QTOFsplash10-0159-0090000000-1d849ba5ea2b160d11d52021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Vadimezan 20V, Positive-QTOFsplash10-000i-0090000000-df0ce6dc9c1a64a9d7742021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Vadimezan 40V, Positive-QTOFsplash10-0pbi-2960000000-31d7cd2b322c340ec6852021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Vadimezan 10V, Negative-QTOFsplash10-000i-0090000000-5fed5dd8afcf2a250ae82021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Vadimezan 20V, Negative-QTOFsplash10-000i-0090000000-264165165bc48fe0c5b42021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Vadimezan 40V, Negative-QTOFsplash10-0kmr-0980000000-9dd30c2643f6ffed38af2021-10-12Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB06235
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkVadimezan
METLIN IDNot Available
PubChem Compound123964
PDB IDNot Available
ChEBI ID75934
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]